- Home
- NAYA
NAYA
NAYA BIOSCIENCES INC
as 02-04-2025 4:00pm EST
Stocks
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $2.00 | AVG Volume (30 days): | 329.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.80 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.41 - $3.50 | Next Earning Date: | 11-19-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | 148.37% |
Latest NAYA BIOSCIENCES INC News
NAYA Breaking Stock News: Dive into NAYA Ticker-Specific Updates for Smart Investing
GlobeNewswire
23 days ago
NAYA Biosciences Announces Pricing of $9.5 Million Public Offering
GlobeNewswire
a month ago
NAYA Biosciences Announces Development of NY-500, a Novel AI-Optimized PD-1 x VEGF Bifunctional Antibody
GlobeNewswire
3 months ago
NAYA Biosciences to Present Translational Insights to Support Phase I/IIa Clinical Trials for its GPC3-Targeting NK Engager Bispecific Antibody at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Share on Social Networks:
Disclaimer
The information presented on this page, "NAYA NAYA BIOSCIENCES INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.